| Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study D Adams, M Polydefkis, A González-Duarte, J Wixner, AV Kristen, ... The Lancet Neurology 20 (1), 49-59, 2021 | 123 | 2021 |
| Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation HH Schmidt, J Wixner, V Planté-Bordeneuve, F Muñoz-Beamud, L Lladó, ... American Journal of Transplantation 22 (6), 1646-1657, 2022 | 38 | 2022 |
| Quality of life in functional movement disorders is as altered as in organic movement disorders T Gendre, G Carle, F Mesrati, C Hubsch, T Mauras, E Roze, M Houot, ... Journal of psychosomatic research 116, 10-16, 2019 | 38 | 2019 |
| Natural history and impact of treatment with tafamidis on major cardiovascular outcome‐free survival time in a cohort of patients with transthyretin amyloidosis M Bézard, M Kharoubi, A Galat, E Poullot, S Guendouz, P Fanen, ... European Journal of Heart Failure 23 (2), 264-274, 2021 | 37 | 2021 |
| Charcot–Marie–Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study F Hauw, G Fargeot, D Adams, S Attarian, C Cauquil, JB Chanson, ... European journal of neurology 28 (9), 2846-2854, 2021 | 28 | 2021 |
| AA amyloidosis secondary to adult onset Still's disease: About 19 cases M Delplanque, J Pouchot, S Ducharme-Bénard, BJ Fautrel, A Benyamine, ... Seminars in Arthritis and Rheumatism 50 (1), 156-165, 2020 | 20 | 2020 |
| Cerebral fat embolism in sickle cell disease S Gendreau, M Scholer, J Cecchini, A Habibi, K Razazi, N De Prost, ... American Journal of Hematology 95 (2), E41-E45, 2020 | 16 | 2020 |
| Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy T Gendre, V Planté-Bordeneuve Clinical Autonomic Research 29, 25-31, 2019 | 15 | 2019 |
| Acute respiratory failure in a patient with stiff-person syndrome V Jachiet, L Laine, T Gendre, C Henry, D Da Silva, E de Montmollin Neurocritical care 25, 455-457, 2016 | 14 | 2016 |
| Clinical description of the broad range of neurological presentations of COVID-19: a retrospective case series LC de Langavant, A Petit, QTR Nguyen, T Gendre, J Abdelhedi, ... Revue Neurologique 177 (3), 275-282, 2021 | 13 | 2021 |
| Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival M Kharoubi, D Bodez, M Bézard, A Zaroui, A Galat, S Guendouz, ... Amyloid 29 (2), 79-91, 2022 | 6 | 2022 |
| Ataxia aguda inducida por el abuso de óxido nitroso en adultos jóvenes durante la pandemia de COVID-19 T Gendre, H Ovaska, R Nguyen, AC Bachoud-Levi, M Khellaf, P Remy Emergencias (Sant Vicenç dels Horts), 225-227, 2023 | 4 | 2023 |
| Characterizing Acute-Onset Small Fiber Neuropathy T Gendre, JP Lefaucheur, T Nordine, Y Baba-Amer, FJ Authier, J Devaux, ... Neurology: Neuroimmunology & Neuroinflammation 11 (2), e200195, 2024 | 3 | 2024 |
| A patient with distal lower extremity neuropathic pain and anti-contactin-associated protein-2 antibodies. T Gendre, JP Lefaucheur, J Devaux, A Créange Muscle & Nerve 64 (3), E15-E17, 2021 | 3 | 2021 |
| Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area Y Dawudi, L Azoyan, TDE Broucker, T Gendre, A Miloudi, ... Journal of Neurology 271 (6), 3340-3346, 2024 | 1 | 2024 |
| Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France T Damy, A Zaroui, M de Tournemire, M Kharoubi, R Gounot, A Galat, ... Archives of cardiovascular diseases 116 (10), 433-446, 2023 | 1 | 2023 |
| Patisiran, an RNAi therapeutic agent in hereditary transthyretin amyloid polyneuropathy: first experience in the real life T Gendre, A Wahab, A Ladaique, F Gorram, P Le Corvoisier, D Bodez, ... EUROPEAN JOURNAL OF NEUROLOGY 26, 189-189, 2019 | 1 | 2019 |
| Quality of life and psychiatric comorbidities comparisons in patients with functional (psychogenic) and organic movement disorders T Gendre, G Carle, F Mesrati, M Houot, B Degos, B Garcin MOVEMENT DISORDERS 33, S475-S475, 2018 | 1 | 2018 |
| Clinical, paraclinical and outcome features of 166 patients with acute anti-GQ1b antibody syndrome M Coly, D Adams, S Attarian, F Bouhour, JP Camdessanché, G Carey, ... Journal of Neurology, 1-9, 2024 | | 2024 |
| Le blocage de l’IL6: une approche efficace dans les neuropathies induites par les inhibiteurs de checkpoint immunitaire corticorésistantes: à propos de quatre cas C Baek, N Kramkimel, T Gendre, M Mongin, T Maisonobe, C Birzu, ... Revue Neurologique 180, S57, 2024 | | 2024 |
